$KYNB 3 SEC Filings

Filed On	Filing
06 Oct 2026	Form 3: Singer Andrew E., Director No securities owned
06 Jun 2025	Form 3: Kauffman Michael, Director No securities owned
18 Dec 2024	Form 3: DeLucia David, Chief Financial Officer Holds 118,462 shares of Common Stock
24 Apr 2024	Form 3: Adib Deyaa, Chief Medical Officer Holds 60,000 shares of Common Stock
09 Sep 2021	Form 3: Graham Juan, Chief Financial Officer Holds 1,400 shares of Common Stock
03 Dec 2020	Form 3: Eisner Mark, Incoming Chief Medical Officer Holds 0 shares of No securities held
07 Aug 2020	Form 3: Cravatt Benjamin, Director Holds 0 shares of No securities held
07 Aug 2020	Form 3: Brennan Aoife, Director Holds 0 shares of No securities held
24 Jun 2020	Form 3: Wettig Thane, Chief Commercial Officer Holds 600 shares of Common Stock
08 Jan 2020	Form 3: Conterno Enrique A, Director Holds 0 shares of Common Stock
12 Jun 2019	Form 3: Blaug Suzanne, Director Holds 0 shares of No securities held
09 May 2019	Form 3: Chung Christine, SVP, China Operations Holds 157,937 shares of Common Stock
09 May 2019	Form 3: Kouchakji Elias, SVP, Clinical Dev, Drug Safety Holds 97,512 shares of Common Stock
07 Dec 2018	Form 3: Ho Maykin, Director No securities owned
21 Sep 2017	Form 3: Lema Gerald, Director Holds 0 shares of Common Stock
30 Oct 2015	Form 3: Edwards Jeffrey L, Director No securities owned
13 Aug 2015	Form 3: Henderson Jeffrey William, Director No securities owned
13 Nov 2014	Form 3: Tamura Toshinari, Director
13 Nov 2014	Form 3: Astellas Pharma Inc., 10% owner
13 Nov 2014	Form 3: Yu K Peony, VP, Clinical Development Holds 143,000 shares of Common Stock

Comments